1
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Infections by Ampicillin-Resistant Enterococci: a Case-Control Study

, , , , , , & show all
Pages 121-126 | Published online: 15 Jul 2016

References

  • Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev 1990; 3: 46–65.
  • Moellering RC Jr. Emergence of Enterococcus as a significant pathogen. Clin Infect Dis 1992; 14: 1173–1178.
  • Schaberg DR. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991; 91 (suppl 3B): 72S-75S.
  • Bush LM, Calmon J, Cherney CL, et al. High-level penicillin resistance among isolates of enterococci. Implications for treatment of enterococcal infection. Ann Intern Med 1989; 110: 515–520.
  • Sapico FL, Canawati HN, Ginunas VJ et al. Enterococci highly resistant to penicillin and ampicillin: an emerging problem? J Clin Microbiol 1989; 27: 2091–2095.
  • Chirurgi VA, Oster SE, Goldberg AA, McCabe RE. Nosocomial acquisition of beta-lactamase-negative, ampicillinresistant Enterococcus. Arch Intern Med 1992; 152: 1457–1461.
  • Spera RV, Farber BF. Multiply-resistant Enterococcus faecium. The nosocomial pathogen of the 1990s. JAMA 1992; 268: 2563–2564.
  • Gray JW, Stewart D, Pedler SJ. Species identification and antibiotic susceptibility testing of enterococci isolated from hospitalized patients. Antimicrob Agents Chemother 1991; 35: 1943–1945.
  • Cercenado E, Garcia-Leoni ME, Rodeno P, Rodriguez-Creixems M. Ampicillin resistant enterococci. J Clin Microbiol 1990; 28: 829.
  • Bartolini A, Stefani S, Orsi A, Nicoletti A, Difonzo AR, Paradisi F. High-level aminoglycoside resistance among enterococci isolates from blood cultures. J Antimicrob Che mother 1992; 31: 729–730.
  • Venditti M, Tarasi A, Gelfusa V, Nicastri E, Penni A, Martino P. Antimicrobial susceptibilities of enterococci isolated from hospitalized patients. Antimicrob Agents Chemother 1993; 37: 1190–1192.
  • Moellering RC Jr. Enterococcal infections in patients treated with moxalactam. Rev Infect Dis 1982; 4: 5708–5711.
  • Bryce EA, Zemcov SJV, Clarke AM. Species identification and antibiotic resistance patterns of the enterococci. Eur J Clin Microbiol Infect Dis 1991; 10: 745–747.
  • Grayson ML, Eliopoulos GM, Wennersten CB et al. Comparison of Enterococcus raffinosus with Enterococcus avium on the basis of penicillin susceptibility, penicillin-binding protein analysis, and high-level aminoglycoside resistance. Antimicrob Agents Chemother 1991; 35: 1408–1412.
  • National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 2nd ed. Approved standard M7-A2. National Committee for Laboratory Standards, Villanova, PA. 1990.
  • Mc Cabe WR, Jackson GG. Gram negative bacteremia. II. Clinical, laboratory and therapeutic observations. Arch Intern Med 1962; 110: 856–864.
  • Murray BE, Mederski-Samoray B. Transferable beta-lactamase: a new mechanism for in vitro penicillin resistance in Streptococcus faecalis. J Clin Invest 1983; 72: 1168–1171.
  • Boyce JN, Opal SM, Potter-Bynoe G et al. Emergence and nosocomial transmission of ampicillin-resistant enterococci. Antimicrob Agents Chemother 1992; 36: 1032–1039.
  • Livornese LL, Dias S, Samel C et al. Hospital-acquired infection with vancomycin-resistant E. faecium transmitted by electronic thermometers. Ann Intern Med 1992; 117: 112–116.
  • Montecalvo MA, Gedris C, Issah A et al. An outbreak of vancomycin-resistant E faecium in an adult oncology unit. In Program and Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology. Washington DC 1992: 305 Abstr No 1169.
  • Johnson CC, Taylor S, Pitsakis P, May P, Levison ME. Bactericidal activity of ramoplanin against antibiotic resistant enterococci. Antimicrob Agents Chemother 1992; 36: 2342–2345.
  • Venditti M, Tarasi A, Baiocchi P, Lamonaca V, Testure GP. The activity «in vitro» of trospectomycin against high-level antibiotic-resistant enterococci. Int J Antimicrob Agents (in press).
  • Goldstein BP, Berti M, Ripamonti F, Resconi A, Scotti R, Denaro M. In vitro antimicrobial activity of a new antibiotic, MDL 62,879 (GE 2270 A). Antimicrob Agents Chemother 1993; 37: 741–745.
  • King A, Bethune L, Phillips I. In vitro activity of MDL 62,879 (GE 2270 A) against aerobic Gram positive and anaerobic bacteria. Antimicrob Agents Chemother 1993; 37: 746–749.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.